You are here: All Products  > Summit Expands Rights for Akeso’s PD-1/VEGF Bispecific in $70 Million Agreement

Summit Expands Rights for Akeso’s PD-1/VEGF Bispecific in $70 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products